1. Mini-Review on Chemical Similarity and Prediction of Toxicity
2. Guideline on aspects of the application of Article 8(1) and (3) of Regulation (EC) No 141/2000: assessing similarity of medicinal products versus authorised orphan medicinal products benefiting from market exclusivity and applying derogations from that market exclusivity. Official J. Eur. Union 2008, C242, 12.
3. Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts ‘similar medicinal product’ and ‘clinical superiority’. Official J. Eur. Union 2000, L103, 5.
4. Chronic myeloid leukaemia as a model of disease evolution in human cancer
5. Zimmermann, J. Pyrimidinderivate und Verfahren zu ihrer Herstellung. Eur. Pat. Appl. 564,409, March 25, 1993.